The latest closing stock price for Apogee Therapeutics as of January 21, 2025 is 39.46.
An investor who bought $1,000 worth of Apogee Therapeutics stock at the IPO in 2023 would have $859 today, roughly 1 times their original investment - a 36.33% compound annual growth rate over 2 years.
The all-time high Apogee Therapeutics stock closing price was 69.80 on March 13, 2024.
The Apogee Therapeutics 52-week high stock price is 72.29, which is 83.2% above the current share price.
The Apogee Therapeutics 52-week low stock price is 32.78, which is 16.9% below the current share price.
The average Apogee Therapeutics stock price for the last 52 weeks is 48.60.
An investor who bought $1,000 worth of Apogee Therapeutics stock at the IPO in 2023 would have $859 today, roughly 1 times their original investment - a 36.33% compound annual growth rate over 2 years.
The all-time high Apogee Therapeutics stock closing price was 69.80 on March 13, 2024.
The Apogee Therapeutics 52-week high stock price is 72.29, which is 83.2% above the current share price.
The Apogee Therapeutics 52-week low stock price is 32.78, which is 16.9% below the current share price.
The average Apogee Therapeutics stock price for the last 52 weeks is 48.60.